Vol. 77, September 2009

Frequency of Fcg Receptor IIIa-158V Polymorphisms in Egyptian Children with Immune Thrombocytopenic Purpura

User Rating:  / 0
PoorBest 

Frequency of Fcg Receptor IIIa-158V Polymorphisms in Egyptian Children with Immune Thrombocytopenic Purpura,NAGUIB ZOHEIR, LAMEES RAGAB, AZZA ABOUL ENEIN, NEIRMINE A. EL-DESSOKI, DOAA M.A. SOLIMAN, IMAN ABDEL WAHAB and MEHRY EL-SOBKY

 

Abstract
Immune thrombocytopenic purpura (ITP) is a bleeding disorder of infants, children and adults. The majority of affected children have the acute form of ITP, defined by duration of thrombocytopenia (<150 x 109/L) of <6 months. Previous studies have shown that Fc gamma receptor (FcyRs) play crucial roles in platelet phagocytosis; antibodies bound to platelets have their Fc portion exposed which allows binding to monocytes/macrophages that express Fc receptors for IgG (FcyRs).
The FcyRIIIa Valine (V) has increased affinity for three separate IgG subclasses when compared with the FcyRIIIa Phenylalanine (F).
The aim of the present study was to assess the frequency of occurrence of the high affinity allelic variant FcyRIIIa-158V in Egyptian children with ITP in comparison to normal individuals.
Determination of FcyRIIIa genotype was performed for 30 ITP patients and 10 healthy control subjects by nested PCR followed by RFLP analysis.
In our study, the allelic frequency of FcyRIIIa-158V was (76.6%) among ITP patient group in contrast to (20%) among the control group. These results suggest that FcyRIIIa-158V/F polymorphism contributes to the pathogenesis of childhood ITP by increased clearance of antibody-sensitized platelets by the high affinity FcyRIIIa-158V allelic variant. Besides the epidemiologic and pathophysiologic interest, this knowl-edge may be of use in the future designing of novel therapeutic interventions.

Show full text

 

Copyright © 2014. All Rights Reserved.
Designer and Developer 
EXPERT WEB SOLUTIONS        0020 1224757188